Spanish medical dermatology company Almirall (BME: ALM) has reported first-half 2026 net sales of 602.7 million euros ($687.1 ...

US pharma major Johnson & Johnson has reported positive top-line Phase III data showing that a dual bispecific antibody ...

UK gene therapy company EpilepsyGTx has named Teresa Nunes as its chief medical officer, tasking her with steering lead ...

US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) today announced recommendations for the approval of ...

A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the ...

Last week saw AstraZeneca sign an accord with China’s Dizal Pharmaceutical for rights to the latter’s lung cancer drug ...

US pharma majors Gilead Sciences and Merck & Co have reported detailed Phase III data showing that their investigational once ...

US clinical-stage biotech Kairos Pharma saw its shares close down 12.6% at $0.31 yesterday, despite announcing a strategic ...

Sanofi has announced changes to its executive committee, as the French pharma major streamlines senior leadership under chief ...

French health company Opella revealed it has inaugurated a new state-of-the-art production line for Enterogermina in Mexico ...

US immunology specialist Celldex yesterday reported mixed top-line results from the company’s Phase II study of barzolvolimab ...